InMed Pharmaceuticals (INM) Profit After Tax (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Profit After Tax of -$3.0 million for Q1 2026, down 39.86% year-over-year from -$4.9 million in Q1 2025, and down 46.25% quarter-over-quarter from -$2.0 million in Q4 2025.
InMed Pharmaceuticals (INM) Profit After Tax (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Profit After Tax history runs 8 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 39.86% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$8.5 million (down 1.76% YoY), while the FY2025 annual figure was -$8.2 million, down 6.49% from the prior year.
- Profit After Tax for Q1 2026 stood at -$3.0 million, down from -$2.0 million in the prior quarter.
- The five-year high for Profit After Tax was -$300000.0 in Q2 2023, with the low at -$7.9 million in Q2 2022.
- The 5-year median for Profit After Tax is -$2.0 million (2025), against an average of -$2.5 million.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax soared 96.19% in 2023, then slumped 566.67% in 2024.
- InMed Pharmaceuticals' Profit After Tax stood at -$2.1 million in 2022, then climbed by 29.65% to -$1.5 million in 2023, then slumped by 74.2% to -$2.6 million in 2024, then advanced by 21.23% to -$2.0 million in 2025, then slumped by 46.25% to -$3.0 million in 2026.
- Business Quant data shows INM's Profit After Tax at -$3.0 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.52 Mn | 1.28 Mn | - | -2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | -2.03 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | -2.58 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -1.48 Mn |
| Sep 30, 2023 | -2.54 Mn |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | -2.10 Mn |
| Sep 30, 2022 | -3.51 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -3.48 Mn |
| Dec 31, 2021 | -4.28 Mn |
| Sep 30, 2021 | -2.97 Mn |
| Jun 30, 2021 | -3.26 Mn |